Navigation Links
DURECT Corporation Announces Third Quarter 2010 Financial Results
Date:11/3/2010

hold worldwide rights.TRANSDUR-Sufentanil is our proprietary transdermal patch intended to deliver sufentanil to chronic pain sufferers for a period of up to seven days from a single application.•

ORADUR-ADHD Program.  In July 2010, we commenced a Phase I clinical trial in this program with multiple formulations. ORADUR-ADHD applies our proprietary ORADUR technology to a leading active pharmaceutical ingredient for the treatment of attention deficit disorder (ADHD). Under an agreement with Orient Pharma, we are collaborating to perform a clinical development program through a Phase II study intended to produce a data package that will support later stage development of the drug candidate and subsequent licensing by DURECT. We are responsible for formulation and study design of the pre-defined clinical program, which Orient Pharma will fund and execute.•

Therapeutic Discovery Tax Grant.  In October 2010, DURECT was notified that we have been awarded grants totaling $733,438 under the Patient Protection and Affordable Care Act of 2010 for three qualifying therapeutic discovery projects; we expect to receive this funding in the fourth quarter of 2010.Earnings Conference CallA live audio webcast of a conference call to discuss third quarter 2010 results will be broadcast live over the internet at 4:30 p.m. Eastern Time on November 3 and is available by accessing DURECT's homepage at www.durect.com and clicking "Investor Relations." If you are unable to participate during the live webcast, the call will be archived on DURECT's website under Audio Archive in the "Investor Relations" section.

About DURECT CorporationDURECT is a specialty pharmaceutical company developing innovative drugs for pain and other chronic disea
'/>"/>

SOURCE DURECT Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. DURECT Corporation Invites You to Join Its Second Quarter 2010 Earnings Conference Call
2. DURECT to Present at the BMO Capital Markets Focus on Healthcare Conference
3. DURECT Corporation Secures $50 Million Committed Equity Financing Facility
4. DURECT Reports Data From European Phase IIb Hysterectomy Study of POSIDUR(TM) (SABER(TM)-Bupivacaine)
5. DURECT to Present at the Jefferies Global Life Sciences Conference
6. DURECT to Present at the Rodman & Renshaw Global Healthcare Conference
7. DURECT Corporation Invites You to Join Its First Quarter 2010 Earnings Conference Call
8. DURECT to Present at the Barclays Capital Global Healthcare Conference
9. DURECT to Present at the Cowen and Company Healthcare Conference
10. DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results
11. DURECT and Nycomed Amend POSIDUR(TM) License Agreement to Separate Funding and Control of U.S. and E.U. Clinical Programs and to Expand Territory
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... TAUNTON, Massachusetts , 21. Mai 2013 ... Inc. („OSI"), die die Firmen OMNIlife science® ... Tochtergesellschaften zählt, hat zwei neue, erfahrene Mitglieder ... Mayer , eine erfahrene Führungspersönlichkeit aus ... übernehmen. David Johnson , ...
(Date:5/21/2013)... May 21, 2013  Tom Daulton, CEO of Mammotome, a ... the Year by the Cincinnati chapter ... nominated by another local top executive who is also a ... from Ethicon Endo-Surgery in March of 2010. Daulton will be ... program, presented by Huntington Bank, on May 22. ...
(Date:5/21/2013)... and PHILADELPHIA , May 21, ... introduced its new corporate image and impressive new product developments ... Philadelphia . "After ten years of unerring focus on ... we felt the need to mark the occasion," said founding ... time we have some interesting developments of benefit to our ...
Breaking Medicine Technology:Orthopaedic Synergy Inc. meldet bedeutenden Zuwachs im Vorstand 2Orthopaedic Synergy Inc. meldet bedeutenden Zuwachs im Vorstand 3Tom Daulton, Mammotome CEO, Named ACG Dealmaker of the Year 2Tom Daulton, Mammotome CEO, Named ACG Dealmaker of the Year 3Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia 2Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia 3
... 4 Savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) today ... September 30, 2009, ending the quarter with $67.5 million in ... December 31, 2008. In October 2009, we raised $60.9 ... from an underwritten public offering of 4,945,000 shares of our ...
... Alcatel-Lucent (Euronext Paris and NYSE: ALU ) ... and reliable remote patient monitoring solution, has been cleared ... marketing in the United States. , The Alcatel-Lucent ... monitoring with an easily deployable solution for standard mobile ...
Cached Medicine Technology:Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 2Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 3Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 4Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 5Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 6Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 7Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 8Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 9Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 10Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 11Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 12Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 13Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 14U.S. Food and Drug Administration Clears Alcatel-Lucent Remote Patient Monitoring Solution for Sale in the United States 2U.S. Food and Drug Administration Clears Alcatel-Lucent Remote Patient Monitoring Solution for Sale in the United States 3
(Date:5/21/2013)... 21, 2013 Medical Ministry International ... 2013 Top-Rated Award by GreatNonprofits , the leading provider ... to be named a Top-Rated 2013 Nonprofit,” says Samuel Smith, ... of our over 3000 Volunteers and Staff serving in 22 ... it came from those that have seen our work first ...
(Date:5/21/2013)... transformation on a large scale is the cornerstone ... achieving better outcomes, better value and better experience ... the patient-centered medical home model offers a viable ... Department of Health and Human Services, Agency for ... learn more about the processes and determinants of ...
(Date:5/21/2013)... Mecklenburg EMS Agency (Medic) and ... free Community Wellness Fair to educate the public on health ... held on Wednesday, May 22, 2013 from 4:00 pm until ... Old Mallard Creek Road, Charlotte, NC 29262). , ... the Mecklenburg County Department of Social Services are ...
(Date:5/21/2013)... France: The Orsiro stent, which is a novel ... demonstrated non-inferiority to the Xience Prime everolimus-eluting stent ... lumen loss at nine months in the results ... today. , The BIOFLOW-II substudy used intravascular ultrasound ... assess neointimal hyperplasia and stent apposition at nine ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 The ... on cable networks and cable channels across the country, ... on its YouTube channel. The producers of the series ... in the shipping industry, the manufacturing industry, health-related companies, ... medical facilities and medical practitioners in all parts of ...
Breaking Medicine News(10 mins):Health News:Medical Ministry International Recognized as a 2013 Top-rated Nonprofit By GreatNonprofits.org 2Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 2Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 3Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 4Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 5Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 6Health News:Mecklenburg EMS Agency Teams Up with the YMCA of Greater Charlotte and Others to Educate the Public on Health Related Initiatives 2Health News:Biodegradable stent proves non-inferior to drug-eluting stent 2Health News:In View hosted by Larry King Announces New Videos on its YouTube Channel 2
... Calif., April 10 Integrated,Healthcare Holdings, Inc. (OTC ... Edward S. Gyimah as its Chief Compliance Officer, ... of its,hospitals. Since 2006, Gyimah has worked as ... in establishing and implementing the Company,s,Sarbanes-Oxley compliance program. ...
... males who bring them pebbles to build egg nests. ... flowers guarded by larger males. , New research ... resources will still attempt to trade sexual currency for ... of Michigan School of Public Health. , The exchange ...
... leading pharma services company rated highest in overall ... ... TRIANGLE PARK, N.C., April 10 Quintiles,Transnational Corp. today announced ... placed Quintiles first in,overall satisfaction. Quintiles also rated first in ...
... to be done to extend safety practices, CDC reports ... for several years, reports of foodborne illnesses have remained ... officials said Thursday. , And that leveling off of ... U.S. Centers for Disease Control and Prevention,s goal of ...
... (April 10, 2008) Carotid artery stenting is ... not eligible for surgery, according to a long-term study ... Carotid artery disease, which involves clogging of the arteries ... is a significant risk factor for stroke, making these ...
... Two world-leading companies have,come together to ... features FDA-,cleared, clinically proven light therapy technology ... skin in the face and neck areas., ... Indianapolis-based ETS Tan, the global leader in ...
Cached Medicine News:Health News:IHHI Announces Chief Compliance Officer Appointment 2Health News:Just like penguins and other primates, people trade sex for resources 2Health News:Quintiles Ranks First in Pan-European Clinical Investigator Study 2Health News:Quintiles Ranks First in Pan-European Clinical Investigator Study 3Health News:Foodborne Illnesses Remain Constant in U.S. 2Health News:Foodborne Illnesses Remain Constant in U.S. 3Health News:SAPPHIRE trial shows long-term benefit of carotid stenting as alternative to surgery 2Health News:SAPPHIRE trial shows long-term benefit of carotid stenting as alternative to surgery 3Health News:Rejuvasun(TM) With Omnilux(TM): Industry First to Feature FDA-Cleared, Clinically Proven Light Therapy Technology 2Health News:Rejuvasun(TM) With Omnilux(TM): Industry First to Feature FDA-Cleared, Clinically Proven Light Therapy Technology 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: